Search results - 81 results
Expert report on FLAKKA
Drug Policy Cell. The document combines data from all available resources (hospitals, police, court investigations, prevention & harm reduction initiatives, own research, …) ranging from mid-2022 ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021
Marina; Wirtz, Gil; Tolksdorf, Kristin; Valenciano, Marta; Bacci, Sabrina; Kissling, Esther; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team Source: Eurosurveillance, Volume 28, Issue 47 ...
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.
Anthony; Nicolay, Nathalie; Monge, Susana; VEBIS-Lot4 working group Source: Influenza Other Respir Viruses, Volume 17, Issue 11 (2023) Keywords: Aged COVID-19 COVID-19 Vaccines Electronics Hospitalization ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Patricia CJL; Lazar, Mihaela; Demlová, Regina; Wirtz, Gil; Amerali, Marina; Dürrwald, Ralf; Kunstár, Mihály Pál; Kissling, Esther; Bacci, Sabrina; Valenciano, Marta; I-MOVE-COVID-19 hospital study team; ...
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Marina; Wirtz, Gil; Tolksdorf, Kristin; Valenciano, Marta; Bacci, Sabrina; Kissling, Esther; I-MOVE-COVID-19 hospital study team; VEBIS hospital study team; Members of the I-MOVE-COVID-19 and VEBIS hospital ...
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
booster doses. Here we assessed the COVID-19 vaccine effectiveness against symptomatic infection and hospital admission among those who received the second and third boosters in Belgium administered during and ...
Pyrogen testing of phage therapeutic products
Queen Astrid Military Hospital in Brussels. With a few exceptions, the results on different phages demonstrate that in general pyrogenic contamination is low for most samples. Health Topics: ...
Evaluation of a point-of-care test for the diagnosis of Taenia solium neurocysticercosis in rural southern Tanzania: a diagnostic accuracy study.
METHODS: Patients with epileptic seizures or severe progressive headache were recruited consecutively from three hospitals in southern Tanzania. All patients were tested with the TS POC test. All patients ...
European Antimicrobial Resistance Surveillance For Belgium (EARSBE, EARSBE-URI, EARSBE-AMR)- Data call 2022, including case and data definitions, and instructions for participating laboratories.
Number: r D/2023.14.440/24 Keywords: Acute care hospitals Antimicrobial resistance Bloodstream infection clinical laboratories multidrug resistance urinary tract infection Health Topics: Multidrug ...
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
Chloé Wyndham-Thomas; Koen Blot; Lucy Catteau Source: Euro Surveill, Volume 28, Issue 26 (2023) Keywords: Belgium COVID-19 COVID-19 Vaccines Hospitalization Humans SARS-CoV-2 Vaccine Efficacy Abstract: ...